Does ARIPIPRAZOLE LAUROXIL Cause Injection site mass? 141 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Injection site mass have been filed in association with ARIPIPRAZOLE LAUROXIL (ARISTADA). This represents 3.4% of all adverse event reports for ARIPIPRAZOLE LAUROXIL.
141
Reports of Injection site mass with ARIPIPRAZOLE LAUROXIL
3.4%
of all ARIPIPRAZOLE LAUROXIL reports
0
Deaths
10
Hospitalizations
How Dangerous Is Injection site mass From ARIPIPRAZOLE LAUROXIL?
Of the 141 reports, 10 (7.1%) required hospitalization.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE LAUROXIL. However, 141 reports have been filed with the FAERS database.
What Other Side Effects Does ARIPIPRAZOLE LAUROXIL Cause?
Off label use (1,024)
Needle issue (567)
Injection site pain (426)
Drug ineffective (262)
Weight increased (207)
Product administered at inappropriate site (198)
Hallucination, auditory (172)
Therapeutic response shortened (172)
Underdose (169)
Incorrect dose administered (162)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which ARIPIPRAZOLE LAUROXIL Alternatives Have Lower Injection site mass Risk?
ARIPIPRAZOLE LAUROXIL vs ARIXTRA
ARIPIPRAZOLE LAUROXIL vs ARMODAFINIL
ARIPIPRAZOLE LAUROXIL vs AROMASIN
ARIPIPRAZOLE LAUROXIL vs ARSENIC TRIOXIDE
ARIPIPRAZOLE LAUROXIL vs ARTEMETHER\LUMEFANTRINE